| Withdrawn | The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial. Chronic Ischemic Left Ventricular Dysfunction, Myocardial Infarction | Phase 1 / Phase 2 | 2025-03-01 |
| Withdrawn | Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Infla COVID-19, Acute Respiratory Distress Syndrome, Corona Virus Infection | Phase 1 | 2022-10-01 |
| Completed | Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Diabetes Mellitus, Ischemic Heart Disease | Phase 1 / Phase 2 | 2021-08-16 |
| Recruiting | Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy Non-ischemic Dilated Cardiomyopathy | Phase 2 | 2021-05-07 |
| Withdrawn | Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain Facetogenic Back Pain, Back Pain | Phase 1 / Phase 2 | 2020-12-01 |
| Withdrawn | Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis Cystic Fibrosis | Phase 1 | 2020-12-01 |
| Withdrawn | AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iN Crohn's Disease, Fistulizing Crohn's Disease, Stem Cells | Phase 1 | 2019-12-01 |
| Completed | The CHILD Trial: Hypoplastic Left Heart Syndrome Study. Hypoplastic Left Heart Syndrome | Phase 1 | 2019-10-16 |
| Terminated | Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression. Endothelial Dysfunction, Metabolic Syndrome, Chronic Inflammation | Phase 1 / Phase 2 | 2018-04-12 |
| Terminated | Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression Treatment Resistant Depression | Phase 1 | 2017-10-31 |
| Completed | Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects Diabetes Mellitus, Type 2 | Phase 1 / Phase 2 | 2017-10-20 |
| Completed | The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) Chronic Ischemic Left Ventricular Dysfunction, Myocardial Infarction | Phase 2 | 2014-02-13 |
| Terminated | Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER) Idiopathic Pulmonary Fibrosis (IPF) | Phase 1 | 2013-11-13 |
| Completed | PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Non-ischemic Dilated Cardiomyopathy | Phase 1 / Phase 2 | 2011-05-19 |
| Terminated | Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHE Stem Cell Transplantation, Ventricular Dysfunction, Left | Phase 1 / Phase 2 | 2007-11-01 |